SMS Pharmaceuticals Ltd — Investor Relations & Filings
SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Copy of Newspaper Publication | 2026-05-02 | English | |
| General Updates | 2026-04-30 | English | |
| Action(s) taken or orders passed | 2026-04-29 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | |
| Action(s) initiated or orders passed | 2026-03-31 | English | |
| Trading Window | 2026-03-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42210249 | Copy of Newspaper Publication | 2026-05-02 | English | ||
| 42172549 | General Updates | 2026-04-30 | English | ||
| 42194523 | Action(s) taken or orders passed | 2026-04-29 | English | ||
| 42200803 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | ||
| 42183149 | Action(s) initiated or orders passed | 2026-03-31 | English | ||
| 42189683 | Trading Window | 2026-03-25 | English | ||
| 42219365 | Copy of Newspaper Publication | 2026-03-20 | English | ||
| 42229829 | Monitoring Agency Report | 2026-02-10 | English | ||
| 42248966 | Press Release | 2026-02-09 | English | ||
| 42249158 | Investor Presentation | 2026-02-09 | English | ||
| 42250007 | Copy of Newspaper Publication | 2026-02-09 | English | ||
| 42268547 | Statement of deviation(s) or variation(s) under Reg. 32 | 2026-02-07 | English | ||
| 42268689 | Integrated Filing- Financial | 2026-02-07 | English | ||
| 42268805 | Outcome of Board Meeting | 2026-02-07 | English | ||
| 43928823 | Board Meeting — Board Meeting Intimation | 2026-01-31 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
SMS Pharmaceuticals Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62302/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62302 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62302 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62302 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62302}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SMS Pharmaceuticals Ltd (id: 62302)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.